Área Oncología

Grupo de Investigación en Trasplante Hematopoyético

Carlos Solano Vercet

Jefe de Servicio de Hematología en el Departamento de Hematología y Oncología Médica, Director del Programa de Trasplante Hematopoyético del Hospital Clínico Universitario de Valencia y Profesor Titular de Medicina en la Universidad de Valencia.

Se licenció en Medicina y Cirugía por la Universidad de Valencia en 1981. Posteriormente realizó la Residencia en Hematología y Hemoterapia en el Hospital Universitario La Princesa de Madrid. Después de dos estancias de investigación en el Hospital Hammersmith, Londres y el Medical Center de UCLA, Los Angeles-CA, en 1990 se incorporó como Médico Adjunto de Hematología del Hospital Clínico de Valencia. Obtuvo el doctorado en Medicina por la Universidad de Valencia en 1996, realizando investigación sobre la recuperación inmune después de trasplante hematopoyético.

Actualmente es Presidente del Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH) y Coordinador del Comité de Inmunoterapia/Enfermedad injerto contra huésped, del GETH.

Es autor de más de 100 artículos originales en revistas de la especialidad, con especial interés en la investigación de la biología y tratamiento de la enfermedad injerto contra huésped y de las complicaciones infecciosas del paciente inmunodeprimido

 

Grupo de Investigación en Trasplante Hematopoyético

Investigador colaborador

Ariadna Pérez Martínez
Paula Amat Martínez
Estela Giménez Quiles
March Poch Martell
Ana Isabel Usero Ruiz
Cristina Arbona Castaño
Maria José Remigia Pellicer
David Navarro Ortega
Rosa Goterris Viciedo

Técnico

Joana Hernández Martín

Data Manager

Marisol Gallego Hernández
Patricia Mañas Carbonero
  • Desarrollo de proyectos y publicación de artículos y presentación a congresos relacionados con la investigación de la recuperación inmune específica, detección precoz de infecciones postrasplante hematopoyético y de nuevas estrategias en la prevención o tratamiento de infecciones postrasplante hematopoyético.
  • Ejecución de proyectos en investigación en predisposición genética y de nuevos fármacos o estrategias en la prevención y el tratamiento de la enfermedad injerto contra huésped postrasplante alogénico
  • Avanzar en el estudio del valor de las células madre mesenquimales para el tratamiento de la enfermedad injerto contra huésped crónico con el estudio colaborativo con CABIMER fruto del convenio Comunidad Andaluza, CSIC y Universidades de Sevilla y Pablo Olavide.
Número total de publicaciones: 104. Factor de Impacto acumulado: 487.52
Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
Orti G, Sanz J, Bermudez A, Caballero D, Martinez C, Sierra J, Cabrera Marin JR, Espigado I, Solano C, Ferrà C, García-Noblejas A, Jimenez S, Sampol A, Yañez L, García-Gutiérrez V, Pascual MJ, Jurado M, Moraleda JM, Valcarcel D, Sanz MA, Carreras E, Duarte RF
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation.. 2016 Mar. 584-8. FI: 3.404
Performance characteristics of the new Abbott Real Time MTB assay for detection of Mycobacterium tuberculosis complex in respiratory specimens.
Vinuesa V, Navarro D, Poujois S, Zaragoza S, Borrás R
Diagnostic microbiology and infectious disease.. 2016 Mar. 212-4. FI: 2.457
Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood.
Solano C, Giménez E, Piñana JL, Vinuesa V, Poujois S, Zaragoza S, Calabuig M, Navarro D
Bone marrow transplantation.. 2016 May. 718-21. FI: 3.57
Lack of evidence for a reciprocal interaction between bacterial and cytomegalovirus infection in the allogeneic stem cell transplantation setting.
Vinuesa V, Solano C, Giménez E, Piñana JL, Hernández Boluda JC, Amat P, Navarro D
Transplant international: official journal of the European Society for Organ Transplantation.. 2016 Aug 16. . FI: 2.835
Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.
Torre-Cisneros J, Aguado JM, Caston JJ, Almenar L, Alonso A, Cantisán S, Carratalá J, Cervera C, Cordero E, Fariñas MC, Fernández-Ruiz M, Fortún J, Frauca E, Gavaldá J, Hernández D, Herrero I, Len O, Lopez-Medrano F, Manito N, Marcos MA, Martín-Dávila P, Monforte V, Montejo M, Moreno A, Muñoz P, Navarro D, Pérez-Romero P, Rodriguez-Bernot A, Rumbao J, San Juan R, Vaquero JM, Vidal E, Spanish Society of Transplantation (SET), Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases and Clinical Microbiology (GESITRA-SEIMC), Spanish Network for Research in Infectious Diseases (REIPI)
Transplantation reviews.. 2016 Apr 28. . FI: 3.816
Successful treatment of hepatitis C virus infection with sofosbuvir and simeprevir in the early phase of an allogeneic stem cell transplant.
Piñana JL, Serra MÁ, Hernández-Boluda JC, Navarro D, Calabuig M, Solano C
Transplant infectious disease: an official journal of the Transplantation Society.. 2016 Feb. 89-92. FI: 2.064
Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease.
Piñana JL, Sanz J, Esquirol A, Martino R, Picardi A, Barba P, Parody R, Gayoso J, Montesinos P, Guidi S, Terol MJ, Moscardó F, Solano C, Arcese W, Sanz MA, Sierra J, Sanz G, GETH GITMO groups
European journal of haematology.. 2016 Feb. 128-35. FI: 2.066
Would Kinetic Analyses of Plasma Cytomegalovirus DNA Load Help to Reach Consensus Criteria for Triggering The Initiation of Preemptive Antiviral Therapy in Transplant Recipients?
Vinuesa V, Giménez E, Solano C, Gimeno C, Navarro D, SEIMC Quality Control Study Group
Clinical infectious diseases: an official publication of the Infectious Diseases Society of America.. 2016 Aug 30. . FI: 8.736000000000001
Re-examining the relationship between active cytomegalovirus (CMV) infection and acute graft-versus-host disease in allogeneic stem cell transplant recipients in the era of real-time PCR CMV assays.
Giménez E, Solano C, Piñana JL, Amat P, Vinuesa V, Navarro D
Transplant international: official journal of the European Society for Organ Transplantation.. 2016 Jan. 126-8. FI: 2.599
Common Genetic Polymorphisms within NF?B-Related Genes and the Risk of Developing Invasive Aspergillosis.
Lupiañez CB, Villaescusa MT, Carvalho A, Springer J, Lackner M, Sánchez-Maldonado JM, Canet LM, Cunha C, Segura-Catena J, Alcazar-Fuoli L, Solano C, Fianchi L, Pagano L, Potenza L, Aguado JM, Luppi M, Cuenca-Estrella M, Lass-Flörl C, Einsele H, Vázquez L, PCRAGA Study Group., Ríos-Tamayo R, Loeffler J, Jurado M, Sainz J
Frontiers in microbiology. 2016 Aug 12. 1243. FI: 4.165
Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders.
Di Minno G, Perno CF, Tiede A, Navarro D, Canaro M, Güertler L, Ironside JW
Blood reviews.. 2016 Jan. 35-48. FI: 5.565
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant.
Solano C, Slavin M, Shaul AJ, Marks DI, Cordonnier C, Cornely OA, Pagliuca A, Cragin L, Jarque I, Garcia-Vidal C, Sorensen S, Vanness DJ, Charbonneau C, Barrueta JA, Peral C, De Salas-Cansado M, Bow EJ
Mycoses.. 2016 Aug 26. . FI: 2.332
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.
Kröger N, Solano C, Wolschke C, Bandini G, Patriarca F, Pini M, Nagler A, Selleri C, Risitano A, Messina G, Bethge W, Pérez de Oteiza J, Duarte R, Carella AM, Cimminiello M, Guidi S, Finke J, Mordini N, Ferra C, Sierra J, Russo D, Petrini M, Milone G, Benedetti F, Heinzelmann M, Pastore D, Jurado M, Terruzzi E, Narni F, Völp A, Ayuk F, Ruutu T, Bonifazi F
The New England journal of medicine.. 2016 Jan 7. 43-53. FI: 55.873
Applying lessons learned from cytomegalovirus infection in transplant patients to vaccine design.
Blanco-Lobo P, Bulnes-Ramos Á, McConnell MJ, Navarro D, Pérez-Romero P
Drug discovery today.. 2016 Apr. 674-81. FI: 6.691
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.
Peyvandi F, Scully M, Kremer Hovinga JA, Cataland S, Knöbl P, Wu H, Artoni A, Westwood JP, Mansouri Taleghani M, Jilma B, Callewaert F, Ulrichts H, Duby C, Tersago D, TITAN Investigators
The New England journal of medicine.. 2016 Feb 11. 511-22. FI: 59.558
High vancomycin MICs within the susceptible range in Staphylococcus aureus bacteraemia isolates are associated with increased cell wall thickness and reduced intracellular killing by human phagocytes.
Falcón R, Martínez A, Albert E, Madrid S, Oltra R, Giménez E, Soriano M, Vinuesa V, Gozalbo D, Gil ML, Navarro D
International journal of antimicrobial agents.. 2016 May. 343-50. FI: 4.296
GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study.
Parody R, López-Corral L, Lopez-Godino O, Martinez C, Martino R, Solano C, Barba P, Caballero D, García-Cadenas I, Piñana JL, Marquez-Malaver FJ, Vazquez L, Esquirol A, Boluda JC, Sanchez-Guijo F, Pérez-Simon JA
Bone marrow transplantation.. 2016 Jun 13. . FI: 3.636
IL28B genetic variation and cytomegalovirus-specific T-cell immunity in allogeneic stem cell transplant recipients.
Corrales I, Solano C, Amat P, Giménez E, de la Cámara R, Nieto J, López J, García-Noblejas A, Piñana JL, Navarro D
Journal of medical virology.. 2016 Sep 3. . FI: 1.998
Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients.
Navarro D, Amat P, de la Cámara R, López J, Vázquez L, Serrano D, Nieto J, Rovira M, Piñana JL, Giménez E, Solano C
Open forum infectious diseases.. 2016 Apr. ofw107
Expanding role of cytomegalovirus as a human pathogen.
Navarro D
Journal of medical virology.. 2016 Jul. 1103-12. FI: 2.347
A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia.
González-Gascón Y Marín I, Hernández-Sánchez M, Rodríguez-Vicente AE, Sanzo C, Aventín A, Puiggros A, Collado R, Heras C, Muñoz C, Delgado J, Ortega M, González MT, Marugán I, de la Fuente I, Recio I, Bosch F, Espinet B, González M, Hernández-Rivas JM, Hernández JÁ, Grupo Español de Leucemia Linfática Crónica (GELLC), Grupo Cooperativo Español de Citogenética Hematológica (GCECGH)
Hematological oncology.. 2016 Jun. 84-92. FI: 3.084
[Homozygous familial hypercholesterolaemia: Spanish adaptation of the position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Consensus document of the Spanish Society of Arteriosclerosis (SEA) an
Ascaso JF, Mata P, Arbona C, Civeira F, Valdivielso P, Masana L
Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis. 2015 Mar-Apr. 80-96
[Optimization strategies in management of CMV infection in transplant patients].
Navarro D
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia.. 2015 Sep. 52-3. FI: 0.797
A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia.
González-Gascón Y Marín I, Hernández-Sánchez M, Rodríguez-Vicente AE, Sanzo C, Aventín A, Puiggros A, Collado R, Heras C, Muñoz C, Delgado J, Ortega M, González MT, Marugán I, de la Fuente I, Recio I, Bosch F, Espinet B, González M, Hernández-Rivas JM, Hernández JÁ, On behalf of Grupo Español de Leucemia Linfática Crónica (GELLC), Grupo Cooperativo Español de Citogenética Hematológica (GCECGH)
Hematological oncology.. 2015 Feb 17. . FI: 3.084
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains.
Cuervo G, Puig-Asensio M, Garcia-Vidal C, Fernández-Ruiz M, Pemán J, Nucci M, Aguado JM, Salavert M, González-Romo F, Guinea J, Zaragoza O, Gudiol C, Carratalà J, Almirante B, CANDIPOP Project, Validation Cohort Project
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.. 2015 Jul. 684.e1-9. FI: 5.768
Association between individual and combined SNPs in genes related to innate immunity and incidence of CMV infection in seropositive kidney transplant recipients.
Fernández-Ruiz M, Corrales I, Arias M, Campistol JM, Giménez E, Crespo J, López-Oliva MO, Beneyto I, Martín-Moreno PL, Llamas-Fuente F, Gutiérrez A, García-Álvarez T, Guerra-Rodríguez R, Calvo N, Fernández-Rodríguez A, Tabernero-Romo JM, Navarro MD, Ramos-Verde A, Aguado JM, Navarro D, OPERA Study Group
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2015 May. 1323-35. FI: 5.683
BCL2 gene polymorphisms and splicing variants in chronic myeloid leukemia.
Guillem V, Amat P, Collado M, Cervantes F, Alvarez-Larrán A, Martínez J, Tormo E, Eroles P, Solano C, Hernández-Boluda JC
Leukemia research.. 2015 Aug 28. . FI: 2.351
Comparison of the performance of 2 commercial multiplex PCR platforms for detection of respiratory viruses in upper and lower tract respiratory specimens.
Costa E, Rodríguez-Domínguez M, Clari MÁ, Giménez E, Galán JC, Navarro D
Diagnostic microbiology and infectious disease.. 2015 May. 40-3. FI: 2.457
Cytomegalovirus Infection Management in Allogeneic Stem Cell Transplant Recipients: a National Survey in Spain.
Solano C, de la Cámara R, Vázquez L, López J, Giménez E, Navarro D
Journal of clinical microbiology. 2015 Aug. 2741-4. FI: 3.993
Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice.
Fernández-Ruiz M, Arias M, Campistol JM, Navarro D, Gómez-Huertas E, Gómez-Márquez G, Díaz JM, Hernández D, Bernal-Blanco G, Cofan F, Jimeno L, Franco-Esteve A, González E, Moreso FJ, Gómez-Alamillo C, Mendiluce A, Luna-Huerta E, Aguado JM, OPERA Study Group
Transplant international : official journal of the European Society for Organ Transplantation. 2015 Sep. 1042-54. FI: 2.599
Detection of fungal DNA in peritoneal fluids by a PCR DNA low-density microarray system and quantitation of serum (1-3)-?-D-glucan in the diagnosis of peritoneal candidiasis.
Corrales I, Giménez E, Aguilar G, Delgado C, Puig J, Izquierdo A, Belda J, Navarro D
Medical mycology : official publication of the International Society for Human and Animal Mycology. 2015 Feb 1. 199-204. FI: 2.335
Effect of delaying prophylaxis against CMV in D+/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease.
San-Juan R, Navarro D, García-Reyne A, Montejo M, Muñoz P, Carratala J, Len O, Fortun J, Muñoz-Cobo B, Gimenez E, Eworo A, Sabe N, Meije Y, Martín-Davila P, Andres A, Delgado J, Jimenez C, Amat P, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Aguado JM, REIPI Network, Spain, GESITRA Study Group from the SEIMC
The Journal of infection.. 2015 Nov. 561-70. FI: 4.441
Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients.
San-Juan R, Navarro D, García-Reyne A, Montejo M, Muñoz P, Carratala J, Len O, Fortun J, Muñoz-Cobo B, Gimenez E, Eworo A, Sabe N, Meije Y, Martín-Davila P, Andres A, Delgado J, Jimenez C, Amat P, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Aguado JM, REIPI Network
Transplant infectious disease : an official journal of the Transplantation Society.. 2015 Oct. 637-46. FI: 2.064
Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.
Giménez E, Solano C, Amat P, de la Cámara R, Nieto J, López J, Garcia-Noblejas A, Navarro D
Journal of medical virology.. 2015 Sep. 1601-7. FI: 2.347
Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study.
Aguilar G, Delgado C, Corrales I, Izquierdo A, Gracia E, Moreno T, Romero E, Ferrando C, Carbonell JA, Borrás R, Navarro D, Belda FJ
BMC research notes. 2015 Sep 29. 491
Expansion of the CRF19_cpx Variant in Spain.
Patiño Galindo JA, Torres-Puente M, Gimeno C, Ortega E, Navarro D, Galindo MJ, Navarro L, Navarro V, Juan A, Belda J, Bracho MA, González-Candelas F, CRIVIH
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2015 Aug. 146-9. FI: 3.016
Fluorescence in situ hybridization analysis does not increase detection rate for trisomy 8 in chronic myelomonocytic leukemia.
Saumell S, Florensa L, Rodríguez-Rivera M, Pedro C, Hernández-Rivas JM, Lumbreras E, Abáigar M, Collado R, Ivars D, Carbonell F, Marugán I, Tormo M, Botia M, Piñan MÁ, Ancín I, González T, Varela ND, Grau J, Granada I, Ruiz N, Martín ML, Fernández-Guijarro M, Duarte JJ, Calasanz MJ, Larrayoz MJ, Solé F
Leukemia & lymphoma. 2015 Jan. 242-3. FI: 2.891
Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes.
Sánchez-Castro J, Marco-Betés V, Gómez-Arbonés X, García-Cerecedo T, López R, Talavera E, Fernández-Ruiz S, Ademà V, Marugan I, Luño E, Sanzo C, Vallespí T, Arenillas L, Marco Buades J, Batlle A, Buño I, Martín Ramos ML, Blázquez Rios B, Collado Nieto R, Vargas MT, González Martínez T, Sanz G, Solé F, Spanish Group for Mds Study (GESMD) and the Spanish Group for Clinical Cytogenetics (Gcecgh)
Leukemia & lymphoma.. 2015 Nov. 3183-8. FI: 2.891
Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.
Giménez E, Muñoz-Cobo B, Solano C, Amat P, de la Cámara R, Nieto J, López J, Remigia MJ, Garcia-Noblejas A, Navarro D
Transplant infectious disease : an official journal of the Transplantation Society.. 2015 Jun. 361-70. FI: 2.064
GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT.
Parody R, Lopez-Corral L, Godino OL, Cadenas IG, Martinez AP, Vazquez L, Martino R, Martinez C, Solano C, Barba P, Valcarcel D, Caballero-Velazquez T, Marquez-Malaver FJ, Sierra J, Caballero D, Perez-Simón JA
Bone marrow transplantation. 2015 Jan. 121-6. FI: 3.57
Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes.
Corrales I, Giménez E, Solano C, Amat P, de la Cámara R, Nieto J, Garcia-Noblejas A, Navarro D
Journal of medical virology. 2015 Feb. 248-55. FI: 2.347
Influence of Age and HLA Alleles on the CMV-Specific Cell-Mediated Immunity Among CMV-Seropositive Kidney Transplant Candidates.
Fernández-Ruiz M, Corrales I, Amat P, González E, Andrés A, Navarro D, Aguado JM
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.. 2015 Sep. 2525-6. FI: 5.683
Intra- and Interinstitutional Evaluation of an Etest for Vancomycin Minimum Inhibitory Concentration Measurement in Staphylococcus aureus Blood Isolates.
Falcón R, Madrid S, Tormo N, Casañ C, Albert E, Gimeno C, Navarro D
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 2015 Nov 1. 1490-2. FI: 8.885999999999999
Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients.
Ferrà C, Sanz J, Díaz-Pérez MA, Morgades M, Gayoso J, Cabrera JR, Villaescusa T, Sampol MA, Fernández-Avilés F, Solano C, Ortín M, Duarte R, Cuesta M, Heras I, de la Serna J, Moraleda JM, Barrenetxea C, González-Vicent M, Sanz G, Ribera JM, Grupo Español de Trasplante Hematopoyético (Geth) Spanish Society of Hematology
Leukemia & lymphoma. 2015 Mar. 656-62. FI: 2.891
Overcoming drug resistance in HSV, CMV, HBV and HCV infection.
López-Labrador FX, Berenguer M, Navarro D
Future microbiology.. 2015 Nov. 1759-66. FI: 4.275
Pharmacoeconomic Analysis of The Use of Voriconazole, Posaconazole And Micafungin In The Primary Prophylaxis of Invasive Fungal Infections In Recipients of Allogeneic Hematopoietic Stem Cell Transplants In Spain.
Grau S, Solano C, García-Vidal C, Jarque I, Barrueta J, Peral C, Rodríguez I, Rubio-Rodríguez D, Rubio-Terrés C
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.. 2015 Nov. A581. FI: 3.279
Plasma metabolomics profiling for the prediction of cytomegalovirus DNAemia and analysis of virus–host interaction in allogeneic stem cell transplant recipients.
Monleón D, Giménez E, Muñoz-Cobo B, Morales JM, Solano C, Amat P, Navarro D
The Journal of general virology.. 2015 Nov. 3373-81. FI: 3.183
Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: Results from the AspBIOmics Consortium.
Lupiañez CB, Canet LM, Carvalho A, Alcazar-Fuoli L, Springer J, Lackner M, Segura-Catena J, Comino A, Olmedo C, Ríos R, Fernández-Montoya A, Cuenca-Estrella M, Solano C, López-Nevot MÁ, Cunha C, Oliveira-Coelho A, Villaescusa T, Fianchi L, Aguado JM, Pagano L, López-Fernández E, Potenza L, Luppi M, Lass-Flörl C, Loeffler J, Einsele H, Vazquez L, PCRAGA Study Group, Jurado M, Sainz J
Infection and immunity.. 2015 Dec 14. 643-57. FI: 3.731
Role of cytomegalovirus (CMV)-specific polyfunctional CD8+ T-cells and antibodies neutralizing virus epithelial infection in the control of CMV infection in an allogeneic stem-cell transplantation setting.
Giménez E, Blanco-Lobo P, Muñoz-Cobo B, Solano C, Amat P, Pérez-Romero P, Navarro D
The Journal of general virology.. 2015 Sep. 2822-31. FI: 3.183
Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.
Aguado JM, Vázquez L, Fernández-Ruiz M, Villaescusa T, Ruiz-Camps I, Barba P, Silva JT, Batlle M, Solano C, Gallardo D, Heras I, Polo M, Varela R, Vallejo C, Olave T, López-Jiménez J, Rovira M, Parody R, Cuenca-Estrella M, PCRAGA Study Group, Spanish Stem Cell Transplantation Group, the Study Group of Medical Mycology of the Spanish Society of Clinical Microbiology and Infectious Diseases, and the Spanish Network for Research in Infectious Diseases
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015 Feb 1. 405-14. FI: 8.885999999999999
Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.
Bow EJ, Vanness DJ, Slavin M, Cordonnier C, Cornely OA, Marks DI, Pagliuca A, Solano C, Cragin L, Shaul AJ, Sorensen S, Chambers R, Kantecki M, Weinstein D, Schlamm H
BMC infectious diseases. 2015 Mar 17. 128. FI: 2.613
The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation.
Noriega V, Martínez-Laperche C, Buces E, Pion M, Sánchez-Hernández N, Martín-Antonio B, Guillem V, Bosch-Vizcaya A, Bento L, González-Rivera M, Balsalobre P, Kwon M, Serrano D, Gayoso J, de la Cámara R, Brunet S, Rojas-Contreras R, Nieto JB, Martínez C, Gónzalez M, Espigado I, Vallejo JC, Sampol A, Jiménez-Velasco A, Urbano-Ispizua A, Solano C, Gallardo D, Díez-Martín JL, Buño I, Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)
PLoS hub for clinical trials. 2015. e0140454. FI: 3.234
The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. accuracy in a multicenter series of 372 patients.
Chen-Liang TH, Martin-Santos T, Jerez A, Senent L, Orero MT, Remigia MJ, Muiña B, Romera M, Fernandez-Muñoz H, Raya JM, Fernandez-Gonzalez M, Lancharro A, Villegas C, Carlos Herrera J, Frutos L, Luis Navarro J, Uña J, Igua C, Sanchez-Vaño R, Cozar Mdel P, Contreras J, Sanchez-Blanco JJ, Perez-Ceballos E, Ortuño FJ
American journal of hematology. 2015 Aug. 686-90. FI: 3.798
Active cytomegalovirus infection is not a risk factor for Epstein-Barr virus DNAemia in the allogeneic stem cell transplantation setting.
Giménez E, Solano C, Bravo D, Amat P, Remigia MJ, Alberola J, Navarro D
Clinical transplantation. 2014 Apr. 508-11. FI: 1.486
An evaluation of the role of NKG2C(+) natural killer cells in protection from cytomegalovirus DNAemia early following allogeneic stem cell transplantation.
Muñoz-Cobo B, Giménez E, Solano C, de la Cámara R, Nieto J, López J, Amat P, Garcia-Noblejas A, Navarro D
Journal of medical virology. 2014 May. 806-11. FI: 2.217
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
Giménez E, Solano C, Nieto J, Remigia MJ, Clari MÁ, Costa E, Muñoz-Cobo B, Amat P, Bravo D, Benet I, Navarro D
Journal of medical virology. 2014 Apr. 568-75. FI: 2.217
Anidulafungin dosing in critically ill patients with continuous venovenous haemodiafiltration.
Aguilar G, Azanza JR, Carbonell JA, Ferrando C, Badenes R, Parra MA, Sadaba B, Navarro D, Puig J, Miñana A, Garcia-Marquez C, Gencheva G, Gutierrez A, Marti FJ, Belda FJ
The Journal of antimicrobial chemotherapy. 2014 Jun. 1620-3. FI: 5.439
Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT.
Ruggeri A, Sanz G, Bittencourt H, Sanz J, Rambaldi A, Volt F, Yakoub-Agha I, Ribera JM, Mannone L, Sierra J, Mohty M, Solano C, Nabhan S, Arcese W, Gluckman E, Labopin M, Rocha V
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 2014 Apr. 779-86. FI: 9.379
Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain.
Ostermann H, Solano C, Jarque I, Garcia-Vidal C, Gao X, Barrueta JA, De Salas-Cansado M, Stephens J, Xue M, Weber B, Charbonneau C
BMC pharmacology & toxicology. 2014 Sep 24. 52
Early kinetics of plasma cytomegalovirus DNA load in allogeneic stem cell transplant recipients in the era of highly sensitive real-time PCR assays: does it have any clinical value?
Giménez E, Muñoz-Cobo B, Solano C, Amat P, Navarro D
Journal of clinical microbiology. 2014 Feb. 654-6. FI: 4.232
Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients.
Bravo D, Solano C, Giménez E, Remigia MJ, Corrales I, Amat P, Navarro D
Journal of medical virology. 2014 May. 838-44. FI: 2.217
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.
Puig-Asensio M, Padilla B, Garnacho-Montero J, Zaragoza O, Aguado JM, Zaragoza R, Montejo M, Muñoz P, Ruiz-Camps I, Cuenca-Estrella M, Almirante B, CANDIPOP Project, GEIH-GEMICOMED (SEIMC), REIPI
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2014 Apr. O245-54. FI: 5.197
Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence a
Corrales I, Giménez E, Navarro D
Clinical and vaccine immunology : CVI. 2014 May. 684-8. FI: 2.37
HIV-2 and HTLV-1 infections in Spain, a non-endemic region.
de Mendoza C, Caballero E, Aguilera A, Pirón M, Ortiz de Lejarazu R, Rodríguez C, Cabezas T, González R, Treviño A, Soriano V, Spanish HIV-2/HTLV Group
AIDS reviews. 2014 Jul-Sep. 152-9. FI: 4.023
Impact of therapeutic strategies on the prognosis of candidemia in the ICU.
Puig-Asensio M, Pemán J, Zaragoza R, Garnacho-Montero J, Martín-Mazuelos E, Cuenca-Estrella M, Almirante B, Prospective Population Study on Candidemia in Spain (CANDIPOP) Project, Hospital Infection Study Group (GEIH), Medical Mycology Study Group (GEMICOMED) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Spanish Network for Research in Infectious Diseases
Critical care medicine. 2014 Jun. 1423-32. FI: 6.147
Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.
Fernández-Ruiz M, Aguado JM, Almirante B, Lora-Pablos D, Padilla B, Puig-Asensio M, Montejo M, García-Rodríguez J, Pemán J, Ruiz Pérez de Pipaón M, Cuenca-Estrella M, CANDIPOP Project, GEIH-GEMICOMED (SEIMC), REIPI
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014 May. 1413-21. FI: 9.416
Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
Puiggros A, Venturas M, Salido M, Blanco G, Fernandez-Rodriguez C, Collado R, Valiente A, Ruiz-Xivillé N, Carrió A, Ortuño FJ, Luño E, Calasanz MJ, Ardanaz MT, Piñán MÁ, Talavera E, González MT, Ortega M, Marugán I, Ferrer A, Gimeno E, Bellosillo B, Delgado J, Hernández JÁ, Hernández-Rivas JM, Espinet B, Grupo Cooperativo Español de Citogenética Hematológica (GCECGH), Grupo Español de Leucemia Linfática Crónica (GELLC)
Genes, chromosomes & cancer. 2014 Sep. 788-97. FI: 3.836
JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events.
Alvarez-Larrán A, Bellosillo B, Pereira A, Kerguelen A, Carlos Hernández-Boluda J, Martínez-Avilés L, Fernández-Rodríguez C, Gómez M, Lombardía L, Angona A, Ancochea A, Senín A, Longarón R, Navarro B, Collado M, Besses C
American journal of hematology. 2014 May. 517-23. FI: 3.477
Looking for biological factors to predict the risk of active cytomegalovirus infection in non-immunosuppressed critically ill patients.
Bravo D, Clari MA, Aguilar G, Belda J, Giménez E, Carbonell JA, Henao L, Navarro D
Journal of medical virology. 2014 May. 827-33. FI: 2.217
Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.
Guinea J, Zaragoza Ó, Escribano P, Martín-Mazuelos E, Pemán J, Sánchez-Reus F, Cuenca-Estrella M, CANDIPOP Project, GEIH-GEMICOMED (SEIMC), and REIPI
Antimicrobial agents and chemotherapy. 2014. 1529-37. FI: 4.451
Monitoring of trough plasma ganciclovir levels and peripheral blood cytomegalovirus (CMV)-specific CD8+ T cells to predict CMV DNAemia clearance in preemptively treated allogeneic stem cell transplant recipients.
Giménez E, Solano C, Azanza JR, Amat P, Navarro D
Antimicrobial agents and chemotherapy. 2014 Sep. 5602-5. FI: 4.451
Pharmacokinetics of anidulafungin during albumin dialysis.
Aguilar G, Azanza JR, Sádaba B, Badenes R, Ferrando C, Delgado C, Hernández J, Parra MA, Puig J, Carbonell JA, Navarro D, Belda FJ
Critical care (London, England). 2014 Mar 31. 422
Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation.
Vallejo C, Batlle M, Vázquez L, Solano C, Sampol A, Duarte R, Hernández D, López J, Rovira M, Jiménez S, Valcárcel D, Belloch V, Jiménez M, Jarque I, Subcommittee of Non-Infectious Complications of the Grupo Español de Trasplante Hematopoyético (GETH)
Haematologica. 2014 Oct. 1632-7. FI: 5.868
Report of 38 cases of tracheobronchitis in non-immunocompromised patients with dual isolation of Aspergillus in lower respiratory tract samples.
Barberán J, Sánchez-Haya E, del Castillo D, Sanz F, Alcázar B, Malmierca E, ASP Investigator Group
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia. 2014 Jun. 110-4. FI: 0.905
Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.
López-Corral L, Corchete LA, Sarasquete ME, Mateos MV, García-Sanz R, Fermiñán E, Lahuerta JJ, Bladé J, Oriol A, Teruel AI, Martino ML, Hernández J, Hernández-Rivas JM, Burguillo FJ, San Miguel JF, Gutiérrez NC
Haematologica. 2014 Aug. 1365-72. FI: 5.868
A polymorphism in the TYMP gene is associated with the outcome of HLA-identical sibling allogeneic stem cell transplantation.
Guillem V, Hernández-Boluda JC, Gallardo D, Buño I, Bosch A, Martínez-Laperche C, de la Cámara R, Brunet S, Martin C, Nieto JB, Martínez C, Pérez A, Montoro J, Garcia-Noblejas A, Solano C, Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)
American journal of hematology. 2013 Oct. 883-9. FI: 4.138
Acral localized acquired cutis laxa.
Martí N, Monteagudo C, Revert A, Reig I, Gámez L, Jordá E
International journal of dermatology. 2013 Aug. 983-6. FI: 1.342
Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: does -7/7q- detection by FISH have prognostic value?
Ademà V, Hernández JM, Abáigar M, Lumbreras E, Such E, Calull A, Dominguez E, Arenillas L, Mallo M, Cervera J, Marugán I, Tormo M, García F, González T, Luño E, Sanzo C, Martín ML, Fernández M, Costa D, Blázquez B, Barreña B, Marco F, Batlle A, Buño I, Martínez-Laperche C, Noriega V, Collado R, Ivars D, Carbonell F, Vallcorba I, Melero J, Delgado E, Vargas MT, Grau J, Salido M, Espinet B, Melero C, Florensa L, Pedro C, Solé F
Leukemia research. 2013 Apr. 416-21. FI: 2.764
Cardiovascular magnetic resonance-derived intramyocardial hemorrhage after STEMI: Influence on long-term prognosis, adverse left ventricular remodeling and relationship with microvascular obstruction.
Husser O, Monmeneu JV, Sanchis J, Nunez J, Lopez-Lereu MP, Bonanad C, Chaustre F, Gomez C, Bosch MJ, Hinarejos R, Chorro FJ, Riegger GA, Llacer A, Bodi V
International journal of cardiology. 2013 Sep 1. 2047-54. FI: 5.509
Deficit of interleukin-7 in serum of patients with Crohn's disease.
Andreu-Ballester JC, Pérez-Griera J, Garcia-Ballesteros C, Amigo V, Catalán-Serra I, Monforte-Albalat A, Bixquert-Jiménez M, Ballester F
Inflammatory bowel diseases. 2013 Feb. E30-1. FI: 5.119
EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe.
van de Velde CJ, Aristei C, Boelens PG, Beets-Tan RG, Blomqvist L, Borras JM, van den Broek CB, Brown G, Coebergh JW, Cutsem EV, Espin E, Gore-Booth J, Glimelius B, Haustermans K, Henning G, Iversen LH, Han van Krieken J, Marijnen CA, Mroczkowski P, Nagtegaal I, Naredi P, Ortiz H, Påhlman L, Quirke P, Rödel C, Roth A, Rutten HJ, Schmoll HJ, Smith J, Tanis PJ, Taylor C, Wibe A, Gambacorta MA, Meldolesi E, Wiggers T, Cervantes A, Valentini V, European Registration of Cancer Care
European journal of cancer (Oxford, England : 1990). 2013 Sep. 2784-90. FI: 5.061
Finding the right dose of fulvestrant in breast cancer.
Estévez L, Alvarez I, Tusquets I, Seguí MA, Muñoz M, Fernández Y, Lluch A
Cancer treatment reviews. 2013 Apr. 136-41. FI: 6.024
Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study.
Martín M, Ruiz A, Ruiz Borrego M, Barnadas A, González S, Calvo L, Margelí Vila M, Antón A, Rodríguez-Lescure A, Seguí-Palmer MA, Muñoz-Mateu M, Dorca Ribugent J, López-Vega JM, Jara C, Espinosa E, Mendiola Fernández C, Andrés R, Ribelles N, Plazaola A, Sánchez-Rovira P, Salvador Bofill J, Crespo C, Carabantes FJ, Servitja S, Chacón JI, Rodríguez CA, Hernando B, Álvarez I, Carrasco E, Lluch A
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Jul 10. 2593-9. FI: 18.038
Gender is a major factor explaining discrepancies in eye colour prediction based on HERC2/OCA2 genotype and the IrisPlex model.
Martinez-Cadenas C, Peña-Chilet M, Ibarrola-Villava M, Ribas G
Forensic science international. Genetics. 2013 Jul. 453-60. FI: 3.861
Nodular lesion on a woman's earlobe.
López V, Giner F
Actas dermo-sifiliográficas. 2013 Jun. 437-8
Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats.
Di Minno G, Canaro M, Ironside JW, Navarro D, Perno CF, Tiede A, Guertler L
Seminars in thrombosis and hemostasis. 2013 Oct. 779-93. FI: 4.216
Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice.
Di Minno G, Canaro M, Ironside JW, Navarro D, Perno CF, Tiede A, Gürtler L
Haematologica. 2013 Oct. 1495-8. FI: 5.935
Perioperative goal-directed hemodynamic therapy based on radial arterial pulse pressure variation and continuous cardiac index trending reduces postoperative complications after major abdominal surgery: a multi-center, prospective, randomized study.
Salzwedel C, Puig J, Carstens A, Bein B, Molnar Z, Kiss K, Hussain A, Belda J, Kirov MY, Sakka SG, Reuter DA
Critical care (London, England). 2013 Sep 8. R191
Pre-emptive antiviral therapy for active CMV infection in adult allo-SCT patients guided by plasma CMV DNAemia quantitation using a real-time PCR assay: clinical experience at a single center.
Solano C, Muñoz-Cobo B, Giménez E, Remigia MJ, Amat P, Clari MA, Bravo D, Benet I, Montoro J, Navarro D
Bone marrow transplantation. 2013 Jul. 1010-2. FI: 3.541
Psychometric properties of the structured Satisfaction Questionnaire with Gastrostomy Feeding (SAGA-8) for caregivers of children with gastrostomy tube nutritional support.
Martínez-Costa C, Calderón C, Pedrón-Giner C, Borraz S, Gómez-López L
Journal of human nutrition and dietetics : the official journal of the British Dietetic Association. 2013 Apr. 191-7. FI: 1.972
[Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectio
Rodríguez A, Alvarez-Rocha L, Sirvent JM, Zaragoza R, Nieto M, Arenzana A, Luque P, Socías L, Martín M, Navarro D, Camarena J, Lorente L, Trefler S, Vidaur L, Solé-Violán J, Barcenilla F, Pobo A, Vallés J, Ferri C, Martín-Loeches I, Díaz E, López D, López-Pueyo MJ, Gordo F, del Nogal F, Marqués A, Tormo S, Fuset MP, Pérez F, Bonastre J, Suberviola B, Navas E, León C, GETGAG, Infectious Diseases Work Group (GTEI) of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), Infections in Critically Ill Patients Study Group (GEIPC) of Spanish Society of Infectious Diseases and Clinical Microbiology
Medicina intensiva / Sociedad Española de Medicina Intensiva y Unidades Coronarias. 2012 Mar. 103-37. FI: 1.323
A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera.
Hernández-Boluda JC, Pereira A, Cervantes F, Alvarez-Larrán A, Collado M, Such E, Arilla MJ, Boqué C, Xicoy B, Maffioli M, Bellosillo B, Marugán I, Amat P, Besses C, Guillem V
Blood. 2012 May 31. 5221-8. FI: 9.06
Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric Sensititre YeastOne method.
Cantón E, Pemán J, Hervás D, Iñiguez C, Navarro D, Echeverría J, Martínez-Alarcón J, Fontanals D, Gomila-Sard B, Buendía B, Torroba L, Ayats J, Bratos A, Sánchez-Reus F, Fernández-Natal I, FUNGEMYCA Study Group
Journal of clinical microbiology. 2012 Dec. 3921-6. FI: 4.068
Cytomegalovirus infection in solid organ transplantation.
Aguado JM, Navarro D, San Juan R, Castón JJ
Enfermedades infecciosas y microbiología clínica. 2012 Mar. 57-62. FI: 1.478
Donor CTLA-4 Genotype Influences Clinical Outcome after T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donors.
Bosch-Vizcaya A, Pérez-García A, Brunet S, Solano C, Buño I, Guillem V, Martínez-Laperche C, Sanz G, Barrenetxea C, Martínez C, Tuset E, Lloveras N, Coll R, Guardia R, González Y, Roncero JM, Bustins A, Gardella S, Fernández C, Buch J, Gallardo D, GvHD/Immunotherapy committee of the Spanish Group for Hematopoietic Transplant (GETH)
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2012 Jan. 100-5. FI: 3.94
Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia.
Guillem V, Amat P, Cervantes F, Alvarez-Larrán A, Cervera J, Maffioli M, Bellosillo B, Collado M, Marugán I, Martínez-Ruiz F, Hernández-Boluda JC
Leukemia research. 2012 Feb. 174-81. FI: 2.764
Functional profile of cytomegalovirus (CMV)-specific CD8(+) T cells and kinetics of NKG2C(+) NK Cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.
Muñoz-Cobo B, Solano C, Benet I, Costa E, Remigia MJ, de la Cámara R, Nieto J, López J, Amat P, Garcia-Noblejas A, Bravo D, Clari MÁ, Navarro D
Journal of medical virology. 2012 Feb. 259-67. FI: 2.373
Identification of candidate polymorphisms on stress oxidative and DNA damage repair genes related with clinical outcome in breast cancer patients.
Rodrigues P, Furriol J, Bermejo B, Chaves FJ, Lluch A, Eroles P
International journal of molecular sciences. 2012 Dec 5. 16500-13. FI: 2.464
Performance of an immunofiltration assay detecting IgM antibodies against ZEBRA and viral capsid p18 proteins (Immunoquick(®) filtration EBV M) for the diagnosis of heterophile antibody-negative primary Epstein-Barr virus infection in children.
Meza LD, Sancho-Tello S, Muñoz-Cobo B, Costa E, Bravo D, Pazos JM, Corrales I, Marcano X, Tohalino M, Navarro D
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2012 Mar. 270-1. FI: 3.287
Performance of the QuantiFERON-cytomegalovirus (CMV) assay for detection and estimation of the magnitude and functionality of the CMV-specific gamma interferon-producing CD8(+) T-cell response in allogeneic stem cell transplant recipients.
Clari MÁ, Muñoz-Cobo B, Solano C, Benet I, Costa E, Remigia MJ, Bravo D, Amat P, Navarro D
Clinical and vaccine immunology : CVI. 2012 May. 791-6. FI: 2.598
Low rate of detection of active cytomegalovirus (CMV) infection early following acute myocardial infarction.
Núñez J, Chilet M, Blasco ML, Clari MA, Sanjuan R, Muñoz-Cobo B, Bodí V, Costa E, Bravo D, Sanchis J, Miñana G, Navarro D
Atherosclerosis. 2012 May. 295-7. FI: 3.706
Polymyositis after donor lymphocyte infusion.
Montoro J, Hernández-Boluda JC, Arbona C, Solano C
International journal of hematology. 2012 Sep. 386-9. FI: 1.681
Prevalence of Trypanosoma cruzi infection in pregnant Latin American women and congenital transmission rate in a non-endemic area: the experience of the Valencian Health Programme (Spain).
Barona-Vilar C, Giménez-Martí MJ, Fraile T, González-Steinbauer C, Parada C, Gil-Brusola A, Bravo D, Gómez MD, Navarro D, Perez-Tamarit A, Fernandez-Silveira L, Fullana-Montoro A, Borrás R
Epidemiology and infection. 2012 Oct. 1896-903. FI: 2.867
Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen.
Sanz J, Boluda JC, Martín C, González M, Ferrá C, Serrano D, de Heredia CD, Barrenetxea C, Martinez AM, Solano C, Sanz MA, Sanz GF
Bone marrow transplantation. 2012 Oct. 1287-93. FI: 3.541

Inmunobiología de la aloreactividad NK en el trasplante de progenitores hematopoyéticos haploidenticos asociado al uso de ciclofosfamida post-trasplante.

Referencia:
PI15/01396
Investigador principal:
Carlos Solano Vercet
Entidad financiadora:
Instituto de Salud Carlos III
Duración:
01/01/2016 - 31/12/2018
Presupuesto total:
€116.765

Inmunobiología de la infección por el citomegalovirus en el trasplante alogénico de precursores hematopoyéticos haploidéntico asociado al uso de ciclofosfamida postrasplante.

Referencia:
PI15/00090
Investigador principal:
David Navarro Ortega
Entidad financiadora:
Instituto de Salud Carlos III
Duración:
01/01/2016 - 31/12/2018
Presupuesto total:
€98.615